Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $605,207 | $251,575 | $231,588 | $231,183 |
| - Cash | $82,909 | $51,388 | $55,680 | $57,897 |
| + Debt | $126 | $141 | $167 | $183 |
| Enterprise Value | $522,425 | $200,328 | $176,075 | $173,469 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$12 | -$12 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$487 | -$3,280 | -$3,330 | -$1,603 |
| % Margin | – | – | – | – |
| Net Income | -$2,933 | -$5,243 | -$2,950 | $50 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.74 | -0.63 | 0.011 |
| % Growth | 44.6% | -17.5% | -5,987.9% | – |
| Operating Cash Flow | -$910 | -$3,504 | -$2,425 | -$1,494 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$910 | -$3,504 | -$2,425 | -$1,494 |